Skip to main content
. 2019 Sep 18;38(1):20–28. doi: 10.1200/JCO.19.01056

FIG 3.

FIG 3.

(A) Change in skin modified Severity Weighted Assessment Tool (mSWAT) scoring for patient 17 with transient skin flare reaction. (B) Mass cytometry analysis of programmed cell death protein 1 (PD-1) expression of peripheral blood Sézary cells at baseline for 12 patients by skin flare status. (C) Histogram of PD-1 expression of peripheral blood Sézary cells for 12 patients.